Correlation Between Inozyme Pharma and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Inozyme Pharma and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Kalvista Pharmaceuticals.
Diversification Opportunities for Inozyme Pharma and Kalvista Pharmaceuticals
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inozyme and Kalvista is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Kalvista Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.17 times less risky than Kalvista Pharmaceuticals. The stock trades about -0.7 of its potential returns per unit of risk. The Kalvista Pharmaceuticals is currently generating about -0.17 of returns per unit of risk over similar time horizon. If you would invest 1,209 in Kalvista Pharmaceuticals on August 28, 2024 and sell it today you would lose (202.00) from holding Kalvista Pharmaceuticals or give up 16.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Kalvista Pharmaceuticals
Performance |
| Timeline |
| Inozyme Pharma |
| Kalvista Pharmaceuticals |
Inozyme Pharma and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Kalvista Pharmaceuticals
The main advantage of trading using opposite Inozyme Pharma and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |